Microbot Medical MBOT Free cash flow yield
Free cash flow yield at other companies
Other financials
Where this comes from
Calculated from Microbot Medical’s reported figures.
Based on trailing twelve months.
The official record: Microbot Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Microbot Medical's free cash flow yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Microbot Medical's free cash flow yield?
- Microbot Medical (MBOT) reported free cash flow yield of -9.5% in Q1 2026.
- How has Microbot Medical's free cash flow yield changed year-over-year?
- Microbot Medical's free cash flow yield increased by 46.4% year-over-year, from -17.7% to -9.5%.
- What is the long-term trend for Microbot Medical's free cash flow yield?
- Over 4 years (2020 to 2025), Microbot Medical's free cash flow yield has grown at a -10.2% compound annual growth rate (CAGR), from -15% to -9.8%.
- What does free cash flow yield mean?
- Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.